Andover, MA, United States of America

Sergei I Agoulnik

This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Eisai R&d Management Co., Ltd., Eisai Inc.. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergei I Agoulnik. Retrieved from https://idiyas.com/inventor/sergei-i-agoulnik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0

 

 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Andover, MA (US) (2017)
  • Wilmington, MA (US) (2009 - 2021)

Company Filing History:


Years Active: 2009-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents. Here is an article about inventor Sergei I Agoulnik:

Title: Unveiling Sergei I Agoulnik: A Pioneer in Cancer Treatment Innovations

Introduction:

Sergei I Agoulnik is a distinguished inventor known for his groundbreaking work in the field of cancer treatment. With a location in Andover, MA (US), Agoulnik has revolutionized the industry with his unique approaches and inventive solutions.

Latest Patents:

Agoulnik boasts an impressive portfolio of five patents, with his latest contributions focusing on Multikinase inhibitors for use in the treatment of cancer. These compounds, along with pharmaceutical compositions and predictive methods, have paved the way for more effective and personalized treatment strategies.

Career Highlights:

Having worked at prominent institutions like Eisai R&D Management Co., Ltd. and Eisai Inc., Agoulnik has honed his skills and expertise in the realm of oncology research. His commitment to pushing boundaries and challenging the status quo has earned him recognition among his peers in the industry.

Collaborations:

Throughout his career, Agoulnik has collaborated with esteemed professionals such as Yimin Jiang and Xiang-Yi Li. These partnerships have not only enriched his work but also led to the development of innovative solutions that continue to impact the field of cancer research.

Conclusion:

In conclusion, Sergei I Agoulnik stands as a visionary inventor whose relentless pursuit of excellence has transformed the landscape of cancer treatment. His patents, career highlights, and collaborative efforts underscore his commitment to advancing the boundaries of innovation in the healthcare sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…